Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a global leader in allogeneic cellular medicines for inflammatory diseases, today ...
In 1986, the World Health Organization released the Pain Relief Ladder (Figure 1). [3] The principle is that the lowest effective dose of an opioid should be used to minimize the impact of its ...
VistaGen Therapeutics Inc . (NASDAQ:VTGN) reported a net loss of $14.1 million for the third quarter of fiscal year 2025, compared to a net loss of $6.4 million in the same period last year. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback